|
|
|
| |
|
|
| |
|
|
| |
Herzog CA, Murakami
MM, Davis GK, Quist HE, Dahlmeier BA, Collins
AJ, Apple FSv:
Prognostic
value of cardiac troponin testing in end stage
renal disease.
Journal
of the American Society of Nephrology 11:
272 A, September 2000 |
|
| |
|
|
| |
Nissenson AR, Owen
W, Collins A, Szczech L, Muhlbaier L, McMahill
CN:
Disease
management improves survival in dialysis patients.
Journal
of the American Society of Nephrology 11:
238 A, September 2000 |
|
| |
|
|
| |
Nissenson AR, Owen
W, Collins A, Szczech L, Muhlbaier L, McMahill
CN:
Disease
management decreases morbidity in dialysis
patients.
Journal
of the American Society of Nephrology 11:
238 A, September 2000 |
|
| |
|
|
| |
Collins A, Snyder
J, Ma JZ:
Relative
risk of death by state: hemodialysis vs. peritoneal
dialysis.
Journal of the American
Society of Nephrology 11: 227 A, September
2000 |
|
| |
|
|
| |
Collins A, Snyder
J, Ma JZ:
Likelihood
of transplantation by state: hemodialysis
vs. peritoneal dialysis.
Journal of the American
Society of Nephrology 11: 228 A, September
2000 |
|
| |
|
|
| |
Collins A, Snyder
J, Ma JZ:
Trends
in the relative risk of transplantation and
death comparing incident hemodialysis and
peritoneal dialysis populations.
Journal of the American
Society of Nephrology 11: 227 A, September
2000 |
|
| |
|
|
| |
Collins A, Snyder
J, Ebben J, Ma JZ:
Trends
in the relative risk of changing dialysis
modalities.
Journal of the American
Society of Nephrology 11: 227-228 A, September
2000 |
|
| |
|
|
| |
Collins A, Snyder
J, Ma JZ, Chen S:
The
problems of competing risks and informative
censoring when comparing the survival of hemodialysis
and peritoneal dialysis patients.
Journal of the American
Society of Nephrology 11: 228 A, September
2000 |
|
| |
|
|
| |
Collins A, St.
Peter WL, Li SY, Ebben J, Chen S, Ma JZ:
Hematocrit levels
36-<39% are associated with lower hospitalization
risk in Medicare hemodialysis patients.
Journal of the American
Society of Nephrology 11: 262 A, September
2000 |
|
| |
|
|
| |
Collins A, Li SY,
Manning W, Ebben J, St. Peter WL, Ma JZ:
The impact of hospitalization,
blood transfusions, and vascular access procedures
on the likelihood of improving low hematocrit
levels.
Journal of the American
Society of Nephrology 11: 261 A, September
2000 |
|
| |
|
|
| |
Collins A, Li SY,
St. Peter WL, Ebben J, Ma JZ:
Changing hematocrit
levels: clinical predictors for hemodialysis
patients to move from low (<30%) to higher
(>30%) hematocrit levels.
Journal of the American
Society of Nephrology 11: 261 A, September
2000 |
|
| |
|
|
| |
Collins A, Li SY,
St. Peter WL, Manning W, Ebben J, Ma JZ:
Changing hematocrit
levels are associated with future Medicare
expenditures.
Journal of the American
Society of Nephrology 11: 262 A, September
2000 |
|
| |
|
|
| |
Collins A, St.
Peter WL, Li SY, Ebben J, Chen S, Ma JZ:
Mortality outcomes
in incident hemodialysis patients with hematocrit
levels $36% are not different from hematocrit
levels 33-<36%.
Journal of the American
Society of Nephrology 11: 249 A, September
2000 |
|
| |
|
|
| |
St. Peter WL, Roberts
T, Ma JZ, Chen S, Collins A:
Rate
of rise in US hematocrit levels and erythropoietin
doses may be stabilizing.
Journal of the American
Society of Nephrology 11: 300 A, September
2000 |
|
| |
|
|
| |
Xue JL, Ma JZ,
Agodoa LY, Collins AJ:
Biochemical
characteristics of patients at initiation:
Peritoneal dialysis vs. hemodialysis in the
United States.
XXXVII
ERA-EDTA Congress, Nice, France, September
18, 2000 |
|
| |
|
|
| |
Xue JL, Ebben J,
Snyder J, Chen SC, Ma J, Pan W, Collins A:
Geographic
and clinical comparison between peritoneal
and hemodialysis patients.
National
Kidney Foundation Clinical Nephrology Meeting
2000, April 13-16, 2000, Atlanta, Georgia |
|
| |
|
|
| |
Xue JL, Snyder
J, Ebben J, Chen SC, Ma J, Pan W, Collins
A:
Peritoneal
dialysis versus hemodialysis: differences
in transplantation and modality change.
National Kidney
Foundation Clinical Nephrology Meeting 2000,
April 13-16, 2000, Atlanta, Georgia |
|
| |
|
|
| |
Xue JL, Collins
AJ:
Projecting
the number with patients of end-stage renal
disease in the United States to this year
2010.
20th
Annual Conference on Peritoneal Dialysis,
San Francisco, California, February 27-29,
2000 |
|
| |
|
|
| |
Xue JL, Collins
AJ:
Geographical
differences in incidence of end-stage renal
disease in the United States.
20th Annual Conference
on Peritoneal Dialysis, San Francisco, California,
February 27-29, 2000 |
|
| |
|
|
| |
Xue JL, Collins
AJ:
The
relationship between ESRD incidence and mortality
of dialysis patients by geographical locations.
20th Annual
Conference on Peritoneal Dialysis, San Francisco,
California, February 27-29, 2000 |
|
| |
|
|
| |
Xue JL, Collins
AJ:
Dialytic
modality change and its association with mortality
of end-stage renal disease by geographical
locations.
20th
Annual Conference on Peritoneal Dialysis,
San Francisco, California, February 27-29,
2000 |
|
| |
|
|
| |
Collins A, Ebben
J, Ma J:
Hospitalization
risk for ischemic heart disease in peritoneal
and hemodialysis patients.
20th
Annual Conference on Peritoneal Dialysis,
San Francisco, California, February 27-29,
2000 |
|
| |
|
|
| |
Collins A, Ebben
J, Ma J:
Hospitalization
risk for congestive heart failure in peritoneal
and hemodialysis patients.
20th
Annual Conference on Peritoneal Dialysis,
San Francisco, California, February 27-29,
2000 |
|
| |
|
|
|
| |
|
